Tag: Skin Cancer

Bioniz Therapeutics gets EC orphan drug status for BNZ-1 for CTCL

pallavi123- April 6, 2021

Bioniz Therapeutics has secured orphan drug designation for BNZ-1 from the European Commission (EC) for the treatment of cutaneous T-cell lymphoma (CTCL), a rare type ... Read More

Sanofi, Regeneron secure Libtayo EMA approval for a type of skin cancer

pharmanewsdaily- July 21, 2019

Libtayo EMA approval : The European Commission has given conditional approval for Libtayo (cemiplimab) for the treatment of adult patients with metastatic or locally advanced ... Read More

Novartis skin cancer drug combo bags EC approval for type of melanoma

pharmanewsdaily- September 1, 2018

Novartis has secured approval from the European Commission (EC) for its skin cancer drug combo Tafinlar (dabrafenib) and Mekinist (trametinib) as an adjuvant therapy for ... Read More